TITLE

OCULUS NOW COMPLIANT FOR CONTINUED NASDAQ LISTING

PUB. DATE
December 2013
SOURCE
Medical Device Daily;12/31/2013, Vol. 17 Issue 251, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the compliance of Petaluma, California-based Oculus Innovative Sciences Inc., a healthcare company, with the equity requirement of stockholders for continued listing on the Nasdaq Capital Market.
ACCESSION #
93433004

 

Related Articles

  • Exchange accepts Bacterin plan to regain compliance.  // Medical Device Daily;6/28/2013, Vol. 17 Issue 125, p5 

    The article reports on the announcement by Bacterin International Holdings, a developer of bone graft materials and coatings for medical applications, that the New York Stock Exchange has accepted its plan to regain compliance with the continued listing requirements of the Exchange.

  • Online Tool Evaluates ICD-10's Financial Impact.  // For the Record (Great Valley Publishing Company, Inc.);8/13/2012, Vol. 24 Issue 15, p31 

    The article offers information on the International Classification of Diseases- 9th revision- clinical modification (ICD-10) PlayBook, an online tool to help healthcare organizations and their staff transition to ICD-10, which has the ICD-10 Financial Risk Calculator.

  • Goldstein: Staying the Course With Alacra. BRYNKO, BARBARA // Information Today;Oct2012, Vol. 29 Issue 9, p1 

    The article looks at Alacra, a company that aggregates information databases for its clients. The company's founder Steven Goldstein discusses the company's inception in 1996. Topics include Alacra's large customer base in the financial services industry, the firm's Alacra Book service, which...

  • Med-Tech Notes.  // Medical Device Daily;8/23/2013, Vol. 17 Issue 163, p2 

    This section offers news briefs on the medical device industry, including a notice from the Nasdaq Stock Market received by orthopedic products manufacturer Orthofix stating that the firm is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) and the announcement by molecular diagnostics...

  • Risk management in the NHS: governance, finance and clinical risk. Fenn, Paul; Egan, Tom // Clinical Medicine;Feb2012, Vol. 12 Issue 1, p25 

    No abstract available.

  • Compliance officer hat could take you far.  // Healthcare Risk Management;Feb2011, Vol. 33 Issue 2, p20 

    No abstract available.

  • On-boarding risk tool published.  // Information World Review;4/23/2013, p1 

    The article reports that business information publisher Bureau van Dijk (BvD) has created a tool Compliance Catalyst, to help assess new customer risk. BvD said that the tool helps to streamline the on-boarding process and improve efficiency. The tool is in its final stages of beta development...

  • Nursing director offers reassurance to patients, residents and staff.  // Learning Disability Practice;Apr2013, Vol. 16 Issue 3, p5 

    The article reports that Castlebeck director of nursing and patient safety Debra Moore, who joined the company after the Winterbourne View abuse had been made public, has been credited with revamping its policies and procedures.

  • An in-depth discussion on risk management. Free, Jason // Health Management Technology;Jun2014, Vol. 35 Issue 6, p18 

    The article highlights a conference call among information security executives including Mac McMillan of CynergisTek, Inc., Adam Green of Davis Wright Tremaine, and Sharon Finney of Adventist Healthcare System. McMillan talks about the challenges of engaging healthcare organizations to conduct...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics